Hysbysiad tryloywder gwirfoddol ymlaen llaw
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS Wales Shared Services Partnership
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
UK
Ffôn: +44 1443848585
E-bost: shannon.mason@wales.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: http://www.procurement.wales.nhs.uk
Cyfeiriad proffil y prynwr: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
COVID-19 Reagant Agreement for Anti-body Testing
Cyfeirnod: PHW-STA-438
II.1.2) Prif god CPV
33696500
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
COVID-19 Reagent Agreement for Anti-body Testing
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 3 800 000.00 GBP
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
33696500
II.2.3) Man cyflawni
Cod NUTS:
UKL
II.2.4) Disgrifiad o’r caffaeliad
NHS Wales Shared Service Partnership on behalf of Public Health Wales NHS Trust wish to inform the market that due to the Covid-19 global pandemic they are awarding a contract for the provision of testing kits, equipment, reagents and any other associated consumables required to operate the testing platforms.
The UK government has mandated UK Health Boards and Trusts to carry out antibody and antigen testing for the wider population as well as those working in Healthcare and Care settings.
Therefore in order to enable the provision of these testing kits, equipment, reagent and other associated consumables required to operate the testing platforms, Public Health Wales would like to inform the market that under Regulation 32 (2) (C) of the Public Contracts Regulations 2015 (PCR’s) as detailed in UK Government guidance PPN 01/20 they are awarding a contract to Ortho Diagnostics Clinical.
The Trust has met all the tests for awarding a contract under this regulation due to the immediate risk that COVID-19 poses to the population of Wales.
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
II.2.14) Gwybodaeth ychwanegol
N/A
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Mae’r caffaeliad y tu allan i gwmpas cymhwysiad y gyfarwyddeb
Esboniad:
Coronavirus Disease (COVID-19) is an infection disease caused by a newly discovered Coronavirus.
The UK Government published the requirement for testing to be available for Healthcare professionals, key workers and the wider population of Wales, to monitor and work to prevent the rate of the spread of infection.
Following engagement with the market and the Public Health Wales Microbiology department, the testing kits, equipment, reagent and other associated consumables required to operate the testing platforms were deemed clinically acceptable and the products have been available for immediate purchase within the market.
The award of these products enables the Trust to increase their testing capacity, in line with the expectations and demands of the Welsh Government strategy in tackling the Coronavirus (COVID-19) pandemic.
In these exceptional circumstances, there is no time to run an accelerated procedure in line with PCR’s as there is an urgent requirement for suitable testing kits, equipment, reagents and other associated consumables required to support the use of the testing platforms.
Based on the above, the authority is applying a 10 day standstill period to allow suppliers in the marketplace an opportunity to appeal if they believe they have the capacity to meet the Trusts unique and urgent requirements.
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section V: Dyfarnu contract/consesiwn
Rhif Contract: PHW-STA-438
V.2 Dyfarnu contract/consesiwn
V.2.1) Y dyddiad y daeth y contract i ben/consesiwn
27/05/2020
V.2.2) Gwybodaeth am dendrau
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Ortho Clinical Diagnostics
Felindre Meadows, Pencoed
Bridgend
CF355PZ
UK
NUTS: UK
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y consesiwn a’r prif delerau cyllido (heb gynnwys TAW)
Cyfanswm gwerth y consesiwn/lot: 3 800 000.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
N/A
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=101971.
(WA Ref:101971)
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Ffôn: +44 2079477501
VI.4.3) Gweithdrefn adolygu
Gwybodaeth fanwl gywir am y terfyn(au) amser ar gyfer gweithdrefnau adolygu:
NHS Wales Shared Services Partnership on behalf of Public Health Wales Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments).
VI.5) Dyddiad anfon yr hysbysiad hwn
28/05/2020